Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug treatments for covid-19: living systematic review and network meta-analysis
Reed Siemieniuk, Jessica Bartoszko, Dena Zeraatkar, et al.
BMJ (2020), pp. m2980-m2980
Open Access | Times Cited: 793

Showing 1-25 of 793 citing articles:

A living WHO guideline on drugs for covid-19
Arnav Agarwal, Beverley J. Hunt, Miriam Stegemann, et al.
BMJ (2020), pp. m3379-m3379
Open Access | Times Cited: 947
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19
Derek C. Angus, Lennie Derde, Farah Al-Beidh, et al.
JAMA (2020) Vol. 324, Iss. 13, pp. 1317-1317
Open Access | Times Cited: 755
COVID-19-neutralizing antibodies predict disease severity and survival
Wilfredo F. García-Beltrán, Evan C. Lam, Michael G. Astudillo, et al.
Cell (2020) Vol. 184, Iss. 2, pp. 476-488.e11
Open Access | Times Cited: 704
Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial
Gilmar Reis, Eduardo Augusto dos Santos Moreira-Silva, Daniela Carla Medeiros Silva, et al.
The Lancet Global Health (2021) Vol. 10, Iss. 1, pp. e42-e51
Open Access | Times Cited: 368
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
Kris M. White, Romel Rosales, Soner Yildiz, et al.
Science (2021) Vol. 371, Iss. 6532, pp. 926-931
Open Access | Times Cited: 310
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial
Christopher Butler, Richard Hobbs, Oghenekome Gbinigie, et al.
The Lancet (2022) Vol. 401, Iss. 10373, pp. 281-293
Open Access | Times Cited: 308
COVID-19: breaking down a global health crisis
Saad I. Mallah, Omar Ghorab, Sabrina Al-Salmi, et al.
Annals of Clinical Microbiology and Antimicrobials (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 296
COVID-19 Transmission, Current Treatment, and Future Therapeutic Strategies
Vrishali S. Salian, Jessica Wright, Peter T. Vedell, et al.
Molecular Pharmaceutics (2021) Vol. 18, Iss. 3, pp. 754-771
Closed Access | Times Cited: 292
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials
Cathrine Axfors, Andreas M. Schmitt, Perrine Janiaud, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 271
The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials
Soheil Hassanipour, Morteza Arab‐Zozani, Bahman Amani, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 231
Effect of Early Treatment with Ivermectin among Patients with Covid-19
Gilmar Reis, Eduardo A.S.M. Silva, Daniela C.M. Silva, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 18, pp. 1721-1731
Open Access | Times Cited: 200
Systemic corticosteroids for the treatment of COVID-19
Carina Wagner, Mirko Griesel, Agata Mikołajewska, et al.
Cochrane library (2021) Vol. 2021, Iss. 8
Open Access | Times Cited: 199
Remdesivir for the treatment of COVID-19
Kelly Ansems, Felicitas Grundeis, Karolina Dahms, et al.
Cochrane library (2021) Vol. 2021, Iss. 8
Open Access | Times Cited: 190
Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with Broad-Spectrum Activity against Coronaviruses
Andreas Luttens, Hjalmar Gullberg, Eldar Abdurakhmanov, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 7, pp. 2905-2920
Open Access | Times Cited: 176
A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic
Chris R. Triggle, Devendra Bansal, Hong Ding, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 164
Rheumatic disease and COVID-19: epidemiology and outcomes
Kimme L Hyrich, Pedro Machado
Nature Reviews Rheumatology (2020) Vol. 17, Iss. 2, pp. 71-72
Open Access | Times Cited: 160
Interleukin-6 blocking agents for treating COVID-19: a living systematic review
Lina Ghosn, Anna Chaimani, Theodoros Evrenoglou, et al.
Cochrane library (2021) Vol. 2021, Iss. 3
Open Access | Times Cited: 156
Methylprednisolone in adults hospitalized with COVID-19 pneumonia
Luís Corral-Gudino, Alberto Bahamonde, Francisco Arnaiz-Revillas, et al.
Wiener klinische Wochenschrift (2021) Vol. 133, Iss. 7-8, pp. 303-311
Open Access | Times Cited: 155
Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: A systematic review and network meta-analysis
Paul Oykhman, Fernando Aleman Paramo, Jean Bousquet, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 149, Iss. 4, pp. 1286-1295
Open Access | Times Cited: 150
SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic
Ali A. Rabaan, Shamsah H. Al-Ahmed, Ranjit Sah, et al.
Annals of Clinical Microbiology and Antimicrobials (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 134
Impact of the COVID-19 pandemic on publication dynamics and non-COVID-19 research production
Marc Raynaud, Valentin Goutaudier, Kévin Louis, et al.
BMC Medical Research Methodology (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 119
Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants
Cong Sun, Chu Xie, Guo‐Long Bu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 112
Needleless electrospun phytochemicals encapsulated nanofibre based 3-ply biodegradable mask for combating COVID-19 pandemic
Nikhil Avinash Patil, Prakash M. Gore, Niranjana Jaya Prakash, et al.
Chemical Engineering Journal (2021) Vol. 416, pp. 129152-129152
Open Access | Times Cited: 109
Ivermectin for the Treatment of Coronavirus Disease 2019: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Yuani M. Roman, Paula Alejandra Burela, Vinay Pasupuleti, et al.
Clinical Infectious Diseases (2021) Vol. 74, Iss. 6, pp. 1022-1029
Open Access | Times Cited: 107
Prophylaxis against covid-19: living systematic review and network meta-analysis
Jessica Bartoszko, Reed Siemieniuk, Elena Kum, et al.
BMJ (2021), pp. n949-n949
Open Access | Times Cited: 103
Page 1 - Next Page

Scroll to top